What the study investigated Researchers examined whether remdesivir (RDV), given during a COVID-19 hospitalization, is associated with reduced mortality after discharge among survivors. Using real-world data from three large health systems in Colorado and Utah, the study followed patients who survived their index hospitalization for 6 to 29 months to assess long-term outcomes beyond the…